ChemoCentryx, Inc.
2-oxindole compounds

Last updated:

Abstract:

Oxindole compounds useful for the treatment of CCR(9) mediated conditions or diseases are provided.

Status:
Grant
Type:

Utility

Filling date:

17 Jul 2020

Issue date:

6 Sep 2022